October 2023 in “F1000Research” TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.
August 2023 in “Annales de Dermatologie et de Vénéréologie” This review analyzed data from 237 patients across 27 publications to provide an updated overview of non-scarring alopecia (NSA) in lupus erythematosus (LE) patients. It found that diffuse/patchy NSA and lupus hair are strongly associated with systemic LE activity, show subtle signs of inflammation, and typically respond well to SLE therapy without progressing to scarring alopecia. In contrast, NSA associated with dermal cutaneous LE or lupus panniculitis of the scalp is less commonly linked to SLE and responds better to skin-directed therapies. The study suggests that diffuse/patchy NSA and lupus hair may be variations of a single LE-specific entity and calls for prospective studies to further explore this manifestation.
June 2023 in “F1000Research” A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.
32 citations,
September 1989 in “Medical Clinics of North America” Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.
3 citations,
January 2023 in “Physiological Research” Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.